Resource: Chronic Liver Disease Foundation’s “Triple E For HCV” CME for Recovery Centers

The Chronic Liver Disease Foundation’s “Triple E for HCV:  Engagement, Education, and Eradication of HCV Among Patients with Substance Use Disorders” is an initiative that offers a CME educational component for recovery center staff on the HCV management of patients. The CME resource is aimed toward physicians and health care Read more…

News: Overdose Awareness Day Events & News in Philly

Today is International Overdose Awareness Day. As we take the time to remember friends and community members we’ve lost, we can also show solidarity by showing up for those affected by and fighting the opioid epidemic. Saturday 9/1: Hike Against Heroin on Forbidden Drive : https://www.eventbrite.com/e/international-overdose-awareness-day-hike-against-heroin-tickets-48397960603 Check out https://www.overdoseday.com/ for information about Read more…

**Call for Grant Proposals**: Gilead’s CHIME (Conquering Hepatitis via Micro‐Elimination) Grant

The Gilead Medical Affairs team is looking to support Hepatitis elimination efforts that focus on micro-elimination among smaller and more defined populations, and on addressing gaps in the care cascade. If your elimination goals focus on your specific city or an at-risk demographic, or on a discrete population within a health care Read more…

Resource: How To Clean Your Syringes

This consumer information sheet from the CDC lays out the step-by-step basics of cleaning a syringe in order to prevent the transmission of hepatitis. Geared towards injection drug users, it emphasizes that viral hepatitis can survive on surfaces like cookers.  Download, print and share the information sheet here! 

Grant Opportunity *ENDS AUGUST 20th*: Gilead HIV/HCV No Co-infection Program Call For Proposals

Calling all investigators focused on addressing elimination in HIV/HCV co-infected and high-risk individuals! Gilead’s HIV/HCV No Co-Infection (NoCo) Program intends to support these micro-elimination efforts by giving up to $600,000 per research proposal.  The Letter of Intent submission window closes Monday 8/20. To find out more about the HIV/HCV NoCo Program, Read more…